Deals & business · first seen 4h ago, updated 4h ago
Alnylam alumni lead RNAi biotech City Therapeutics to IPO filing
Biotechs are rushing into the IPO queue. City Therapeutics submitted its public pitch late Thursday, the same night ADARx Pharmaceuticals priced its $446 million Nasdaq debut. Kendall Square-based ...
Summary from Endpoints News.